Skip to main content
Clinical Trials/NCT02430831
NCT02430831
Unknown
Phase 4

Randomized Controlled Trial Testing the Effect of Milk Formula Supplemented With L. Reuteri on Crying Time in Colicky Infants Less Than 3 Months Old

University of Bari1 site in 1 country60 target enrollmentMay 2015
ConditionsInfantile Colic

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Infantile Colic
Sponsor
University of Bari
Enrollment
60
Locations
1
Primary Endpoint
Daily Crying duration
Last Updated
11 years ago

Overview

Brief Summary

Study type:

Randomized controlled trial with two parallel arms Objectives

Primary : Demonstrate that daily supplementation of colicky infants with Nidina formula containing L. reuteri DSM 17938 decreases the daily crying duration at 21 days Secondary : Evaluate the effects of daily supplementation of colicky infants with Nidina formula containing L. reuteri DSM 17938 measured as

  1. the number of "responders" or the "treatment success" (ie infants for which defined as the percentage of children achieving a reduction in the daily average crying time >50% in 3 weeks. (day 1 to day 21 of the study)
  2. maternal depression and family functioning scoring

Detailed Description

Inclusion criteria : * less then 12 weeks of age * term infant (≥ 38 weeks gestational age) * birth weight \> 2,500g * infantile colic diagnosed according to modified Wessel's criteria, i.e. crying more than an average of 180 min/day during the 3 days prior to enrollment. * parental motivation to postpone changes in the infant feeding mode, unless necessary Exclusion criteria: * birth weight less than 2500 g * failure to thrive * chronic illness or major medical problem * gastrointestinal disease * cow's milk allergy ( confirmed prior to exclusion; difficult to diagnose so early ??) * use of any antibiotic or probiotic in the week (7 days) prior to enrollment * use of proton pump inhibitors in the week (7 days) prior to enrollment * if breastfeeding, use of probiotic by the mother in the week (7 days) prior to enrollment * infant receiving solid foods (such as cereals, mashed fruits or vegetable purée) * change of feeding mode planned by parents during the study period Randomization and blinding: to be written by the CRO, according to its own procedures. Extreme caution should be given to blinding. Methods should give full certainty that blinding was perfect at the subject (parent) level, but also at the pediatrician and with all involved personnel. Randomization should be done according to 3 feeding modes : * "breast feeding: only breast, except for 2 bottle feedings a week, * "formula fed": only formula except two breast feeding a week, * "mixed feeding": all the remaining

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
May 2016
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Bari
Responsible Party
Principal Investigator
Principal Investigator

Flavia Indrio

MD

University of Bari

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria :
  • less then 12 weeks of age
  • term infant (≥ 38 weeks gestational age)
  • birth weight \> 2,500g
  • infantile colic diagnosed according to modified Wessel's criteria, i.e. crying more than an average of 180 min/day during the 3 days prior to enrollment.
  • parental motivation to postpone changes in the infant feeding mode, unles

Exclusion Criteria

  • - birth weight less than 2500 g
  • failure to thrive
  • chronic illness or major medical problem
  • gastrointestinal disease
  • cow's milk allergy ( confirmed prior to exclusion; difficult to diagnose so early ??)
  • use of any antibiotic or probiotic in the week (7 days) prior to enrollment
  • use of proton pump inhibitors in the week (7 days) prior to enrollment
  • if breastfeeding, use of probiotic by the mother in the week (7 days) prior to enrollment
  • infant receiving solid foods (such as cereals, mashed fruits or vegetable purée)
  • change of feeding mode planned by parents during the study period

Outcomes

Primary Outcomes

Daily Crying duration

Time Frame: three days

The average crying time in minutes per day measured on day 19, 20, and 21 between active and placebo groups.

Secondary Outcomes

  • Mother depression (mother depression Scale)(One day)
  • Rate of success (decrease in mean daily crying time)(3 days)
  • Family functional score (family functioning scale)(one day)

Study Sites (1)

Loading locations...

Similar Trials